Cardio Diagnostics Holdings, Inc.

CDIO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Assets
Cash & Equivalents $0 $0 $0 $0 $0 $237.1K
Accounts Receivable $8.1K $18.6K $5.0K $0 $901
Inventory
Total Current Assets $5.9M $8.8M $2.8M $5.9M $803.5K
Property, Plant & Equipment $700.1K $672.9K $571.9K
Goodwill
Intangible Assets (Excl. Goodwill) $5.3K $21.3K $37.3K $53.3K
Total Assets $7.8M $10.6M $4.5M $6.2M $1.1M
Liabilities
Accounts Payable
Total Current Liabilities $604.8K $631.7K $841.1K $1.9M $124.4K
Long-Term Debt
Total Liabilities $793.1K $1.1M $1.5M $1.9M $33.9K
Stockholders' Equity
Retained Earnings $-29.3M $-22.8M $-14.4M $-6.0M $-1.3M
Total Stockholders' Equity $7.0M $9.6M $3.0M $4.3M $1.1M $60.4K